Fulgent Genetics (FLGT) Total Liabilities (2015 - 2026)

Fulgent Genetics has disclosed Total Liabilities across 12 years of filings, most recently posting $93.2 million for Q2 2026.

• In Q2 2026, Total Liabilities rose 5.71% year-over-year to $93.2 million; the TTM figure through Jun 2026 stood at $93.2 million (up 5.71% YoY), while the FY2025 annual figure was $106.8 million, up 17.63% from the prior year.
• Total Liabilities came in at $93.2 million for Q2 2026 at Fulgent Genetics, down from $112.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $152.6 million in Q1 2022 to a low of $83.0 million in Q1 2025.
• Average Total Liabilities over 5 years is $106.4 million, with a median of $102.6 million recorded in 2023.
• Year-over-year, Total Liabilities tumbled 39.54% in 2023 and jumped 35.24% in 2026.
• Over 5 years, Total Liabilities stood at $116.2 million in 2022, then slipped by 12.17% to $102.0 million in 2023, then fell by 11.01% to $90.8 million in 2024, then advanced by 17.63% to $106.8 million in 2025, then dropped by 12.71% to $93.2 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $93.2 million in Q2 2026, $112.2 million in Q1 2026, and $106.8 million in Q4 2025.